** = Publikationen gelistet in SCI/SSCI/Pubmed
** Helmlinger, B; Seebacher, B; Ropele, S; Hechenberger, S; Heschl, B; Reishofer, G; Jordan, S; Tinauer, C; Wurth, S; Valsasina, P; Rocca, MA; Filippi, M; Ehling, R; Reindl, M; Khalil, M; Deisenhammer, F; Brenneis, C; Enzinger, C; Pinter, D
Effects of rhythmic-cued gait training on gait-like task related brain activation in people with multiple sclerosis.
J Neurol Sci. 2025; 471: 123426
Doi: 10.1016/j.jns.2025.123426
Web of Science
PubMed
FullText
FullText_MUG
** Hechenberger, S; Helmlinger, B; Jordan, S; Wurth, S; Heschl, B; Damulina, A; Eppinger, S; Khalil, M; Enzinger, C; Pinter, D
Reliable Change Index for the self-administered, IPad-based processing speed test - the PST
MULT SCLER J. 2025; 31(1_SUPPL):
Web of Science
** Helmlinger, B; Hechenberger, S; Hutter, J; Jordan, S; Wurth, S; Damulina, A; Heschl, B; Khalil, M; Enzinger, C; Pinter, D
Distinct contribution of motor function and psychological factors on motor fatigue
MULT SCLER J. 2025; 31(1_SUPPL): P28
Web of Science
** Hechenberger, S; Helmlinger, B; Tinauer, C; Jauk, E; Ropele, S; Heschl, B; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Pinter, D
Evaluation of a self-administered iPad®-based processing speed assessment for people with multiple sclerosis in a clinical routine setting.
J Neurol. 2024; 271(6):3268-3278
Doi: 10.1007/s00415-024-12274-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kiss, C; Wurth, S; Heschl, B; Khalil, M; Gattringer, T; Enzinger, C; Ropele, S
Low-frequency MR elastography reveals altered deep gray matter viscoelasticity in multiple sclerosis.
Neuroimage Clin. 2024; 42: 103606
Doi: 10.1016/j.nicl.2024.103606
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hechenberger, S; Broeders, T; Bet, M; Helmlinger, B; Tinauer, C; Ropele, S; Heschl, B; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Schoonheim, M; Enzinger, C; Pinter, D
Dynamic Brain Functional Connectivity Patterns associated with Fatigue in Multiple Sclerosis
MULT SCLER J. 2024; 30(3): 532-533.
[Poster]
Web of Science
** Pinter, D; Helmlinger, B; Hechenberger, S; Leitner, M; Wurth, S; Damulina, A; Demjaha, R; Khalil, M; Enzinger, C
Predictive value and changes of psychological resilience in people with multiple sclerosis: a longitudinal cohort study
MULT SCLER J. 2024; 30(3): 432-433.
[Poster]
Web of Science
** Schnabl, A; Ellmeier, E; Stracke, A; Seifried, K; Tafrali, C; Demjaha, R; Wurth, S; Khalil, M; Angiari, S
Targeting pyruvate kinase M2 to limit T cell pathogenicity in multiple sclerosis
EUR J IMMUNOL. 2024; 54: 74-74.-7th European Conference of Immunology; SEP 01-04, 2024; Dublin, IRELAND.
[Oral Communication]
Web of Science
** Berek, K; Bauer, A; Rudzki, D; Auer, M; Barket, R; Zinganell, A; Lerch, M; Hofer, L; Grams, A; Poskaite, P; Wurth, S; Berger, T; Di Pauli, F; Deisenhammer, F; Hegen, H; Reindl, M
Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serum
FRONT IMMUNOL. 2023; 14: 1200146
Doi: 10.3389/fimmu.2023.1200146
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hechenberger, S; Helmlinger, B; Penner, IK; Pirpamer, L; Fruhwirth, V; Heschl, B; Ropele, S; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Pinter, D; Enzinger, C
Psychological factors and brain magnetic resonance imaging metrics associated with fatigue in persons with multiple sclerosis.
J Neurol Sci. 2023; 454:120833
Doi: 10.1016/j.jns.2023.120833
Web of Science
PubMed
FullText
FullText_MUG
** Hegen, H; Berek, K; Bsteh, G; Auer, M; Altmann, P; Di Pauli, F; Grams, A; Milosavljevic, D; Ponleitner, M; Poskaite, P; Schnabl, C; Wurth, S; Zinganell, A; Berger, T; Walde, J; Deisenhammer, F
Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort study
EBIOMEDICINE. 2023; 91: 1-9.
Doi: 10.1016/j.ebiom.2023.104573
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Damulina, A; Pirpamer, L; Demjaha, R; Tafrali, C; Wurth, S; Heschl, B; Hochmeister, S; Garcia, JJA; Opriessnig, P; Ropele, S; Enzinger, C; Khalil, M
Intrathecal kappa free light chains indicate higher MRI lesion burden in patients with multiple sclerosis
MULT SCLER J. 2023; 29: 565-565.
[Poster]
Web of Science
FullText
** Demjaha, R; Hechenberger, S; Buchmann, A; Helmlinger, B; Heschl, B; Wurth, S; Opriessnig, P; Ropele, S; Leppert, D; Benkert, P; Kuhle, J; Enzinger, C; Pinter, D; Khalil, M
Serum NfL levels and cognitive performance in persons with multiple sclerosis
EUR J NEUROL. Abstracts. 2023; 30(S1):226-226.-9th Congress of the European Academy of Neurology; JUL 1-4, 2023; Budapest, HUNGARY.
[Poster]
Web of Science
** Demjaha, R; Hechenberger, S; Buchmann, A; Helmlinger, B; Heschl, B; Wurth, S; Opriessnig, P; Ropele, S; Leppert, D; Benkert, P; Kuhle, J; Enzinger, C; Pinter, D; Khalil, M
Serum NfL levels and cognitive performance in persons with multiple sclerosis
MULT SCLER J. 2023; 29: 297-298.-9th Joint ECTRIMS-ACTRIMS meeting; OCT 11-13, 2023; Milan, ITALY.
[Poster]
Web of Science
** Hechenberger, S; Helmlinger, B; Tinauer, C; Fruhwirth, VM; Ropele, S; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Pinter, D
Evaluation of a Self-Administered iPad-Based Test to Measure Processing Speed in People with Multiple Sclerosis
MULT SCLER J. 2023; 29: 190-190.-9th Joint ECTRIMS-ACTRIMS meeting; OCT 11-13, 2023; Milan, ITALY.
[Poster]
Web of Science
FullText
** Hegen, H; Berek, K; Bsteh, G; Auer, M; Altmann, P; Di Pauli, F; Grams, A; Milosavljevic, D; Ponleitner, M; Poskaite, P; Schnabl, C; Wurth, S; Zinganell, A; Berger, T; Walde, J; Deisenhammer, F
Kappa Free Light Chain and Neurofilament Light independently predict early Multiple Sclerosis Disease Activity
EUR J NEUROL. 2023; 30: 49-49.
[Poster]
Web of Science
** Hegen, H; Berek, K; Bsteh, G; Auer, M; Altmann, P; Di Pauli, F; Grams, A; Milosavljevic, D; Ponleitner, M; Poskaite, P; Schnabl, C; Wurth, S; Zinganell, A; Berger, T; Walde, J; Deisenhammer, F
Kappa Free Light Chain and Neurofilament Light independently predict early Multiple Sclerosis Disease Activity
MULT SCLER J. 2023; 29: 897-898.
[Poster]
Web of Science
** Bsteh, G; Hegen, H; Berek, K; Altmann, P; Auer, M; Di Pauli, F; Haider, L; Leutmezer, F; Rommer, P; Walchhofer, LM; Wurth, S; Zinganell, A; Deisenhammer, F; Berger, T
Olfactory threshold predicts treatment response in relapsing multiple sclerosis
MULT SCLER J. 2022; 13524585221079744
Doi: 10.1177/13524585221079744
Web of Science
PubMed
FullText
FullText_MUG
** Hechenberger, S; Helmlinger, B; Fruhwirth, V; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Pinter, D
Evaluation of a Self-administered, IPad-based Processing Speed Test for People with Multiple Sclerosis
MULT SCLER J. 2022; 28(2_SUPPL): 12-13.
[Poster]
Web of Science
** Hechenberger, S; Pirpamer, L; Fruhwirth, V; Berger, L; Helmlinger, B; Wurth, S; Damulina, A; Eppinger, S; Khalil, M; Enzinger, C; Penner, I; Pinter, D
Structural Brain Changes Associated with Fatigue in People with Multiple Sclerosis
EUR J NEUROL. Proceedings of the 8th Congress of the EAN. 2022; 29: 222-222.-8th Congress of the European-Academy-of-Neurology (EAN); JUN 25-28, 2022; Vienna, AUSTRIA.
[Poster]
Web of Science
** Hechenberger, S; Pirpamer, L; Helmlinger, B; Fruhwirth, V; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Penner, IK; Pinter, D
Factors influencing fatigue in persons with multiple sclerosis: contribution of psychological and magnetic resonance imaging assessment
MULT SCLER J. 2022; 28(3_SUPPL): 436-437.
[Poster]
Web of Science
FullText
** Helmlinger, B; Hechenberger, S; Fruhwirth, V; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Pinter, D
Self-efficacy influences depression and anxiety in a cross-sectional cohort of people with multiple sclerosis
MULT SCLER J. 2022; 28(3_SUPPL):907-907.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
** Auer, M; Zinganell, A; Hegen, H; Bsteh, G; Di Pauli, F; Berek, K; Fava, E; Wurth, S; Berger, T; Deisenhammer, F
Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years
SCI REP-UK. 2021; 11(1): 23317
Doi: 10.1038/s41598-021-02665-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Berek, K; Bsteh, G; Auer, M; Di Pauli, F; Grams, A; Milosavljevic, D; Poskaite, P; Schnabl, C; Wurth, S; Zinganell, A; Berger, T; Walde, J; Deisenhammer, F; Hegen, H
Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity
NEUROL-NEUROIMMUNOL. 2021; 8(4): e1005
Doi: 10.1212/NXI.0000000000001005
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bsteh, G; Berek, K; Hegen, H; Altmann, P; Wurth, S; Auer, M; Zinganell, A; Di Pauli, F; Rommer, P; Leutmezer, F; Deisenhammer, F; Berger, T
Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis.
Mult Scler. 2021; 27(5):684-694
Doi: 10.1177/1352458520935724
Web of Science
PubMed
FullText
FullText_MUG
** Bsteh, G; Hegen, H; Altmann, P; Auer, M; Berek, K; Di Pauli, F; Leutmezer, F; Rommer, P; Wurth, S; Zinganell, A; Zrzavy, T; Deisenhammer, F; Berger, T
Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis.
Eur J Neurol. 2021; 19(4):
Doi: 10.1111/ene.14829
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bsteh, G; Hegen, H; Riedl, K; Altmann, P; Auer, M; Berek, K; Di Pauli, F; Ehling, R; Kornek, B; Monschein, T; Rinner, W; Schmied, C; Wurth, S; Zebenholzer, K; Zinganell, A; Zrzavy, T; Zulehner, G; Deisenhammer, F; Rommer, P; Leutmezer, F; Berger, T
Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score.
Eur J Neurol. 2021; 28(5):1609-1616
Doi: 10.1111/ene.14705
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Auer, M; Zinganell, A; Hegen, H; Bsteh, G; Di Pauli, F; Berek, K; Fava, E; Wurth, S; Berger, T; Deisenhammer, F
Treatment of multiple sclerosis with natalizumab: experiences from a real-life cohort over 15 years
MULT SCLER J. ECTRIMS 2021 Abstracts. 2021; 27(2_SUPPL):588-588.-37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; OCT 13-15, 2021; Vienna, AUSTRIA.
[Poster]
Web of Science
** Bsteh, G; Hegen, H; Berek, K; Altmann, P; Auer, M; Di Pauli, F; Leutmezer, F; Rommer, P; Wurth, S; Zinganell, A; Deisenhammer, F; Berger, T
Olfactory threshold predicts treatment response in relapsing multiple sclerosis
MULT SCLER J. ECTRIMS 2021 Abstracts. 2021; 27(2_SUPPL):53-53.-37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; OCT 13-15, 2021; Vienna, AUSTRIA.
[Poster]
Web of Science
** Hechenberger, S; Pirpamer, L; Fruhwirth, V; Berger, L; Helmlinger, B; Wurth, S; Damulina, A; Khalil, M; Enzinger, C; Penner, IK; Pinter, D
Morphological correlates of fatigue in patients with multiple sclerosis
MULT SCLER J. 2021; 27(2_SUPPL): 257-258.
[Poster]
Web of Science
** Hegen, H; Berek, K; Bsteh, G; Auer, M; Di Pauli, F; Grams, A; Milosavljevic, D; Poskaite, P; Schnabl, C; Wurth, S; Zinganell, A; Berger, T; Walde, J; Deisenhammer, F
Kappa free light chains in cerebrospinal fluid predict early multiple sclerosis disease activity
MULT SCLER J. ECTRIMS 2021 Abstracts. 2021; 27(2_SUPPL):505-506.-37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; OCT 13-15, 2021; Vienna, AUSTRIA.
[Poster]
Web of Science
** Bsteh, G; Hegen, H; Altmann, P; Auer, M; Berek, K; Di Pauli, F; Wurth, S; Zinganell, A; Rommer, P; Deisenhammer, F; Leutmezer, F; Berger, T
Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis
MULT SCLER J-EXP TRA. 2020; 6(4): 2055217320966344
Doi: 10.1177/2055217320966344
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Auer, M; Bsteh, G; Hegen, H; Wurth, S; Zinganell, A; Berger, T; Deisenhammer, F; Pauli, FD
Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab.
Mult Scler Relat Disord. 2020; 43(8):102155-102155
Doi: 10.1016/j.msard.2020.102155
Web of Science
PubMed
FullText
FullText_MUG
** Berek, K; Fava, E; Zinganell, A; Hegen, H; Auer, M; Wurth, S; Rhomberg, P; Deisenhammer, F; Di Pauli, F
Transverse myelitis as a rare presentation of antiphospholipid-antibody-associated disorders.
Mult Scler Relat Disord. 2020; 45(10):102405-102405
Doi: 10.1016/j.msard.2020.102405
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Auer, M; Bsteh, G; Hegen, H; Wurth, S; Zinganell, A; Berger, T; Deisenhammer, F; Di Pauli, F
Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab.
MULT SCLER J. 2020; 26(3_SUPPL): 287-287.
[Poster]
Web of Science
** Bsteh, G; Hegen, H; Riedl, K; Altmann, P; Auer, M; Berek, K; Di Pauli, F; Ehling, R; Kornek, B; Monschein, T; Rinner, W; Schmied, C; Wurth, S; Zinganell, A; Zulehner, G; Zrzavy, T; Deisenhammer, F; Rommer, P; Leutmezer, F; Berger, T
Quantifying the risk of disease reactivation after dmt discontinuation - the viaadisc score.
MULT SCLER J. 2020; 26(3_SUPPL): 300-300.
[Poster]
Web of Science